You are here
Cell-Free Protein Labeling for Drug Discovery
Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 2R44GM063369-02
Agency Tracking Number: GM063369
Amount:
$749,938.00
Phase:
Phase II
Program:
SBIR
Solicitation Topic Code:
N/A
Solicitation Number:
PHS2004-2
Timeline
Solicitation Year:
2004
Award Year:
2004
Award Start Date (Proposal Award Date):
N/A
Award End Date (Contract End Date):
N/A
Small Business Information
AMBERGEN, INC.
1106 COMMONWEALTH AVE
BOSTON, MA
02215
United States
DUNS:
N/A
HUBZone Owned:
No
Woman Owned:
No
Socially and Economically Disadvantaged:
No
Principal Investigator
Name: SADANAND Gite
Phone: (617) 975-0683
Email: SADANAND@AMBERGEN.COM
Phone: (617) 975-0683
Email: SADANAND@AMBERGEN.COM
Business Contact
Name: NORMAN PRIEBATSCH
Phone: (617) 975-0688
Email: NEP@AMBERGEN.COM
Phone: (617) 975-0688
Email: NEP@AMBERGEN.COM
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): The human genome has opened a new chapter for drug discovery. In contrast to conventional drug discovery methods, which screen a drug library against a single protein target, the entire protein complement of the genome
* Information listed above is at the time of submission. *